Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Archer Daniels enters technology licensing agreement with Solarea Bio » 10:18
10/19/21
10/19
10:18
10/19/21
10:18
ADM

Archer Daniels

$63.89 /

+0.11 (+0.17%)

Solarea Bio announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADM Archer Daniels
$63.89 /

+0.11 (+0.17%)

ADM Archer Daniels
$63.89 /

+0.11 (+0.17%)

10/12/21
Fly Intel: Top five analyst downgrades
10/12/21 Stephens
Archer Daniels downgraded to Equal Weight from Overweight at Stephens
07/21/21
Fly Intel: Top five analyst initiations
07/21/21 Jefferies
Archer Daniels initiated with a Hold at Jefferies
ADM Archer Daniels
$63.89 /

+0.11 (+0.17%)

ADM Archer Daniels
$63.89 /

+0.11 (+0.17%)

ADM Archer Daniels
$63.89 /

+0.11 (+0.17%)

Yesterday
Hot Stocks
Archer Daniels and enzymes, probiotics maker Vland to launch JV for China » 08:14
10/18/21
10/18
08:14
10/18/21
08:14
ADM

Archer Daniels

$63.94 /

-0.23 (-0.36%)

ADM and Qingdao Vland…

ADM and Qingdao Vland Biotech Group announced that they have agreed to form a joint venture to serve growing Chinese demand for human probiotics. "This exciting new joint venture represents the latest expansion in our full-scale global health & wellness business, which is helping propel growth across our entire human and animal nutrition portfolio, and creating value for ADM and customers alike," said Vince Macciocchi, president of ADM's Nutrition business. "We're excited to partner with Vland to help meet the needs of consumers who are becoming increasingly aware of the strong linkage between health of the gut microbiome and their overall health. Retail demand for probiotics in China is estimated to be $1 billion in 2022, with annual growth of more than 9 percent, and we believe this new venture - powered by the expertise and experience of both ADM and Vland - is perfectly positioned to play a leading role in meeting that demand." The 50-50 joint venture will manufacture and sell human probiotics, bringing together expertise and experience from both ADM and Vland to encompass a full range of technology, production and commercial capabilities, from pre-clinical trial design to manufacturing to go-to-market strategy and execution. The joint venture, which is subject to regulatory approval, is expected to launch in the first half of 2022.

ShowHide Related Items >><<
ADM Archer Daniels
$63.94 /

-0.23 (-0.36%)

ADM Archer Daniels
$63.94 /

-0.23 (-0.36%)

10/12/21
Fly Intel: Top five analyst downgrades
10/12/21 Stephens
Archer Daniels downgraded to Equal Weight from Overweight at Stephens
07/21/21
Fly Intel: Top five analyst initiations
07/21/21 Jefferies
Archer Daniels initiated with a Hold at Jefferies
ADM Archer Daniels
$63.94 /

-0.23 (-0.36%)

ADM Archer Daniels
$63.94 /

-0.23 (-0.36%)

ADM Archer Daniels
$63.94 /

-0.23 (-0.36%)

Hot Stocks
Applied Materials unveils eBeam metrology system » 07:38
10/18/21
10/18
07:38
10/18/21
07:38
AMAT

Applied Materials

$131.57 /

-0.555 (-0.42%)

Applied Materials…

Applied Materials unveiled a unique eBeam metrology system that enables a new playbook for patterning control based on massive on-device, across-wafer and through-layer measurements. The company said, "Advanced chips are built one layer at a time, and each of billions of individual features must be perfectly patterned and aligned to create working transistors and interconnects with optimal electrical characteristics. As the industry increasingly moves from simple 2D designs to more aggressive multipatterning and 3D designs, a commensurate breakthrough in metrology is needed to perfect each critical layer and enable the best performance, power, area-cost and time to market...With the arrival of new eBeam system technology that can directly measure semiconductor device structures across the wafer and through layers at high speed, customers are moving to a new patterning control playbook based on big data. Applied's latest eBeam metrology innovation - the PROVision 3E system - is especially designed for this new playbook."

ShowHide Related Items >><<
AMAT Applied Materials
$131.57 /

-0.555 (-0.42%)

AMAT Applied Materials
$131.57 /

-0.555 (-0.42%)

10/14/21 Piper Sandler
Piper Sandler starts Applied Materials at Neutral with $130 price target
10/14/21 Piper Sandler
Applied Materials initiated with a Neutral at Piper Sandler
10/05/21 Lynx
Lynx would be buyer of Applied Materials, Lam Research amid pullback in semis
10/01/21 Wells Fargo
Wells says Applied Materials CFO exit 'surprising,' but doesn't change thesis
AMAT Applied Materials
$131.57 /

-0.555 (-0.42%)

AMAT Applied Materials
$131.57 /

-0.555 (-0.42%)

AMAT Applied Materials
$131.57 /

-0.555 (-0.42%)

AMAT Applied Materials
$131.57 /

-0.555 (-0.42%)

Thursday
Initiation
Piper Sandler starts Applied Materials at Neutral with $130 price target » 16:17
10/14/21
10/14
16:17
10/14/21
16:17
AMAT

Applied Materials

/

+

Piper Sandler analyst…

Piper Sandler analyst Weston Twigg initiated coverage of Applied Materials with a Neutral rating and $130 price target. While Twigg believes the company should benefit from a multi-year expansion of compute and semiconductor demand, a likely 2023 "digestion period" could limit share upside over the next 12 months, the analyst stated. However, he adds that shareholder returns "should remain high" and that he believes the company's 2024 target model "appears achievable."

ShowHide Related Items >><<
AMAT Applied Materials
/

+

AMAT Applied Materials
/

+

10/14/21 Piper Sandler
Applied Materials initiated with a Neutral at Piper Sandler
10/05/21 Lynx
Lynx would be buyer of Applied Materials, Lam Research amid pullback in semis
10/01/21 Wells Fargo
Wells says Applied Materials CFO exit 'surprising,' but doesn't change thesis
10/01/21 Stifel
Applied Materials' interim CFO appointment 'comforting,' says Stifel
AMAT Applied Materials
/

+

AMAT Applied Materials
/

+

AMAT Applied Materials
/

+

AMAT Applied Materials
/

+

Initiation
Applied Materials initiated with a Neutral at Piper Sandler » 16:11
10/14/21
10/14
16:11
10/14/21
16:11
AMAT

Applied Materials

$131.97 /

+3.7 (+2.88%)

Piper Sandler analyst…

Piper Sandler analyst Weston Twigg initiated coverage of Applied Materials with a Neutral rating and $130 price target.

ShowHide Related Items >><<
AMAT Applied Materials
$131.97 /

+3.7 (+2.88%)

AMAT Applied Materials
$131.97 /

+3.7 (+2.88%)

10/05/21 Lynx
Lynx would be buyer of Applied Materials, Lam Research amid pullback in semis
10/01/21 Wells Fargo
Wells says Applied Materials CFO exit 'surprising,' but doesn't change thesis
10/01/21 Stifel
Applied Materials' interim CFO appointment 'comforting,' says Stifel
09/28/21 New Street
Applied Materials downgraded to Neutral from Buy at New Street
AMAT Applied Materials
$131.97 /

+3.7 (+2.88%)

AMAT Applied Materials
$131.97 /

+3.7 (+2.88%)

AMAT Applied Materials
$131.97 /

+3.7 (+2.88%)

AMAT Applied Materials
$131.97 /

+3.7 (+2.88%)

Recommendations
Steris, Sotera sites on EPA list for required TRI reporting, says Baird » 14:01
10/14/21
10/14
14:01
10/14/21
14:01
STE

Steris

$223.43 /

+3.16 (+1.43%)

, SHC

Sotera Health

$25.89 /

+0.37 (+1.45%)

Baird analyst Mike Polark…

Baird analyst Mike Polark noted that the Environmental Protection Agency has announced a decision to exercise its authority under the Emergency Planning and Community Right-to-Know Act to make Toxic Release Inventory, or TRI, reporting at 31 ethylene oxide sterilization facilities in the U.S., which has previously been voluntary, a mandatory requirement. The 31 facilities selected by the EPA include eight sites owned by Sterigenics, a Sotera Health (SHC) company, and eight sites owned by Steris (STE), noted Polark. He adds that while "none of this is actionable per se" he is watching this "developing, sensitive industry topic." Polark has Outperform ratings on both Sotera Health and Steris.

ShowHide Related Items >><<
STE Steris
$223.43 /

+3.16 (+1.43%)

STE Steris
$223.43 /

+3.16 (+1.43%)

08/11/21 KeyBanc
Steris price target raised to $239 from $227 at KeyBanc
08/11/21 Stephens
Steris price target raised to $255 from $217 at Stephens
08/11/21 Baird
Steris price target raised to $250 from $230 at Baird
05/26/21
Fly Intel: Top five analyst upgrades
SHC Sotera Health
$25.89 /

+0.37 (+1.45%)

07/13/21 Barclays
Sotera Health price target raised to $30 from $29 at Barclays
05/14/21 Barclays
Sotera Health price target lowered to $29 from $35 at Barclays
05/14/21 Citi
Sotera Health selloff brings attractive entry point, says Citi
03/02/21 Barclays
Sotera Health initiated with an Overweight at Barclays
STE Steris
$223.43 /

+3.16 (+1.43%)

SHC Sotera Health
$25.89 /

+0.37 (+1.45%)

  • 18
    Mar
  • 20
    Nov
STE Steris
$223.43 /

+3.16 (+1.43%)

STE Steris
$223.43 /

+3.16 (+1.43%)

Over a week ago
Downgrade
Fly Intel: Top five analyst downgrades » 09:54
10/12/21
10/12
09:54
10/12/21
09:54
LITE

Lumentum

$84.27 /

-1.24 (-1.45%)

, CTXS

Citrix

$92.25 /

-2.53 (-2.67%)

, TREX

Trex Company

$100.18 /

-2.81 (-2.73%)

, ADM

Archer Daniels

$63.44 /

-0.53 (-0.83%)

, FBNC

First Bancorp

$50.00 /

+0.285 (+0.57%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lumentum (LITE) downgraded to Outperform from Strong Buy at Raymond James with analyst Simon Leopold saying Lumentum remains his favorite play on optical components but that its December quarter outlook carries risk. 2. Citrix (CTXS) downgraded to Market Perform from Outperform at William Blair with analyst Jason Ader saying recent discussions with the company's key technology partners "speak to a dire and deteriorating situation at Citrix." 3. Trex Company (TREX) downgraded to Neutral from Outperform at Baird with analyst Timothy Wojs saying decking channel checks suggest sell-through demand will be slower in Q3 and Q4, driven by a combination of material and labor constraints, tougher compares, inflation and seasonality. 4. Archer Daniels (ADM) downgraded to Equal Weight from Overweight at Stephens with analyst Ben Bienvenu saying while he thinks fundamentals remain strong for Archer Daniels, he views the current risk/reward as "more subdued than we've seen" and believes that for the stock to move materially higher, fundamentals will "need to inflect significantly given the stock's current valuation." 5. First Bancorp (FBNC) downgraded to Neutral from Overweight at Piper Sandler with analyst Stephen Scouten saying the shares appear near full value following the recent outperformance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
TREX Trex Company
$100.18 /

-2.81 (-2.73%)

LITE Lumentum
$84.27 /

-1.24 (-1.45%)

FBNC First Bancorp
$50.00 /

+0.285 (+0.57%)

CTXS Citrix
$92.25 /

-2.53 (-2.67%)

ADM Archer Daniels
$63.44 /

-0.53 (-0.83%)

LITE Lumentum
$84.27 /

-1.24 (-1.45%)

10/12/21 Raymond James
Lumentum downgraded to Outperform from Strong Buy at Raymond James
10/05/21 MKM Partners
MKM Partners remains positive on Lumentum opportunity in 3D Sensing
08/19/21 Loop Capital
Lumentum price target raised to $100 from $90 at Loop Capital
08/19/21 Craig-Hallum
Lumentum price target raised to $100 from $90 at Craig-Hallum
CTXS Citrix
$92.25 /

-2.53 (-2.67%)

10/12/21 William Blair
William Blair downgrades Citrix on 'dire and deteriorating situation'
10/12/21 William Blair
Citrix downgraded to Market Perform from Outperform at William Blair
10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 Morgan Stanley
Citrix CEO exit may be followed by long-term strategy shift, says Morgan Stanley
TREX Trex Company
$100.18 /

-2.81 (-2.73%)

10/12/21 Baird
Baird downgrades Trex to Neutral on slower decking demand
10/12/21 Baird
Trex Company downgraded to Neutral from Outperform at Baird
08/03/21 DA Davidson
Trex Company price target lowered to $100 from $108 at DA Davidson
08/03/21 B. Riley
Trex Company price target raised to $108 from $103 at B. Riley
ADM Archer Daniels
$63.44 /

-0.53 (-0.83%)

10/12/21 Stephens
Archer Daniels downgraded to Equal Weight from Overweight at Stephens
07/21/21
Fly Intel: Top five analyst initiations
07/21/21 Jefferies
Archer Daniels initiated with a Hold at Jefferies
05/03/21 Barclays
Archer Daniels price target raised to $75 from $60 at Barclays
FBNC First Bancorp
$50.00 /

+0.285 (+0.57%)

10/12/21 Piper Sandler
First Bancorp downgraded to Neutral from Overweight at Piper Sandler
06/16/21
Fly Intel: Top five analyst upgrades
06/16/21 Piper Sandler
First Bancorp upgraded to Overweight from Neutral at Piper Sandler
11/25/20 Gabelli
First Bancorp downgraded to Hold from Buy at Gabelli
TREX Trex Company
$100.18 /

-2.81 (-2.73%)

LITE Lumentum
$84.27 /

-1.24 (-1.45%)

FBNC First Bancorp
$50.00 /

+0.285 (+0.57%)

CTXS Citrix
$92.25 /

-2.53 (-2.67%)

ADM Archer Daniels
$63.44 /

-0.53 (-0.83%)

TREX Trex Company
$100.18 /

-2.81 (-2.73%)

LITE Lumentum
$84.27 /

-1.24 (-1.45%)

CTXS Citrix
$92.25 /

-2.53 (-2.67%)

ADM Archer Daniels
$63.44 /

-0.53 (-0.83%)

TREX Trex Company
$100.18 /

-2.81 (-2.73%)

LITE Lumentum
$84.27 /

-1.24 (-1.45%)

CTXS Citrix
$92.25 /

-2.53 (-2.67%)

ADM Archer Daniels
$63.44 /

-0.53 (-0.83%)

CTXS Citrix
$92.25 /

-2.53 (-2.67%)

Downgrade
Archer Daniels downgraded to Equal Weight from Overweight at Stephens » 07:51
10/12/21
10/12
07:51
10/12/21
07:51
ADM

Archer Daniels

$64.00 /

+0.71 (+1.12%)

Stephens analyst Ben…

Stephens analyst Ben Bienvenu downgraded Archer Daniels to Equal Weight from Overweight with a price target of $67, up from $65. While he thinks fundamentals remain strong for Archer Daniels, he views the current risk/reward as "more subdued than we've seen" and believes that for the stock to move materially higher, fundamentals will "need to inflect significantly given the stock's current valuation," Bienvenu tells investors. He is lowering his Q3 earnings estimate primarily on lower-than-previously-expected results in the Ag Services and Vantage operating segments given how disruptions from Hurricane Ida likely pushed volumes that would have flowed through Q3 into late Q4 and the first quarter of 2022, Bienvenu added.

ShowHide Related Items >><<
ADM Archer Daniels
$64.00 /

+0.71 (+1.12%)

ADM Archer Daniels
$64.00 /

+0.71 (+1.12%)

07/21/21
Fly Intel: Top five analyst initiations
07/21/21 Jefferies
Archer Daniels initiated with a Hold at Jefferies
05/03/21 Barclays
Archer Daniels price target raised to $75 from $60 at Barclays
04/28/21 BMO Capital
Archer Daniels price target raised to $63 from $56 at BMO Capital
ADM Archer Daniels
$64.00 /

+0.71 (+1.12%)

ADM Archer Daniels
$64.00 /

+0.71 (+1.12%)

ADM Archer Daniels
$64.00 /

+0.71 (+1.12%)

Recommendations
AIG price target raised to $59 from $53 at Barclays » 05:37
10/12/21
10/12
05:37
10/12/21
05:37
AIG

AIG

$57.89 /

+0.285 (+0.49%)

, PLMR

Palomar

$78.43 /

-1.41 (-1.77%)

, ACGL

Arch Capital

$40.18 /

-0.78 (-1.90%)

Barclays analyst Tracy…

Barclays analyst Tracy Benguigui raised the firm's price target on AIG to $59 from $53 and keeps an Equal Weight rating on the shares ahead of the Q3 reporting season. The analyst likes insurers "who truly embrace the cycle by growing through risk optimization." Benguigui anticipates Palomar (PLMR), AIG (AIG) and Arch Capital (ACGL) to show the strongest growth prospects in Q3.

ShowHide Related Items >><<
PLMR Palomar
$78.43 /

-1.41 (-1.77%)

AIG AIG
$57.89 /

+0.285 (+0.49%)

ACGL Arch Capital
$40.18 /

-0.78 (-1.90%)

AIG AIG
$57.89 /

+0.285 (+0.49%)

09/23/21 RBC Capital
AIG price target raised to $65 from $60 at RBC Capital
08/16/21 Wolfe Research
AIG initiated with an Outperform at Wolfe Research
05/10/21 Barclays
AIG price target raised to $53 from $47 at Barclays
05/10/21 RBC Capital
AIG price target raised to $58 from $52 at RBC Capital
PLMR Palomar
$78.43 /

-1.41 (-1.77%)

07/09/21 Piper Sandler
Palomar price target raised to $78 from $70 at Piper Sandler
07/01/21 William Blair
Palomar should progress out of 'penalty box,' says William Blair
04/16/21
Fly Intel: Top five analyst initiations
04/16/21 JMP Securities
Palomar price target lowered to $95 from $105 at JMP Securities
ACGL Arch Capital
$40.18 /

-0.78 (-1.90%)

08/16/21 Wolfe Research
Arch Capital initiated with an Outperform at Wolfe Research
08/16/21 Morgan Stanley
Arch Capital resumed with an Equal Weight at Morgan Stanley
07/09/21 BofA
Progressive added to US 1 List; Arch Capital removed at BofA
04/14/21 RBC Capital
Arch Capital price target raised to $47 from $41 at RBC Capital
PLMR Palomar
$78.43 /

-1.41 (-1.77%)

AIG AIG
$57.89 /

+0.285 (+0.49%)

ACGL Arch Capital
$40.18 /

-0.78 (-1.90%)

AIG AIG
$57.89 /

+0.285 (+0.49%)

AIG AIG
$57.89 /

+0.285 (+0.49%)

ACGL Arch Capital
$40.18 /

-0.78 (-1.90%)

AIG AIG
$57.89 /

+0.285 (+0.49%)

On The Fly
Fly Intel: After-Hours Movers » 18:47
10/11/21
10/11
18:47
10/11/21
18:47
WWR

Westwater Resources

$3.49 /

+0.09 (+2.65%)

, QTRX

Quanterix

$41.23 /

-2.38 (-5.46%)

, GERN

Geron

$1.33 /

+0.005 (+0.38%)

, ACGL

Arch Capital

$40.18 /

-0.78 (-1.90%)

, VCYT

Veracyte

$41.57 /

+0.01 (+0.02%)

, RLAY

Relay Therapeutics

$29.29 /

+1.04 (+3.68%)

Check out this evening's…

ShowHide Related Items >><<
WWR Westwater Resources
$3.49 /

+0.09 (+2.65%)

VCYT Veracyte
$41.57 /

+0.01 (+0.02%)

RLAY Relay Therapeutics
$29.29 /

+1.04 (+3.68%)

QTRX Quanterix
$41.23 /

-2.38 (-5.46%)

GERN Geron
$1.33 /

+0.005 (+0.38%)

ACGL Arch Capital
$40.18 /

-0.78 (-1.90%)

WWR Westwater Resources
$3.49 /

+0.09 (+2.65%)

QTRX Quanterix
$41.23 /

-2.38 (-5.46%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Goldman Sachs
Quanterix initiated with a Sell at Goldman Sachs
05/06/21 SVB Leerink
Quanterix price target lowered to $70 from $85 at SVB Leerink
03/03/21 SVB Leerink
Quanterix price target raised to $85 from $75 at SVB Leerink
GERN Geron
$1.33 /

+0.005 (+0.38%)

02/18/21 B. Riley
Geron transferred with Buy rating at B. Riley Securities
10/14/20 B. Riley
Geron shares have 100% potential upside, says B. Riley Securities
ACGL Arch Capital
$40.18 /

-0.78 (-1.90%)

08/16/21 Wolfe Research
Arch Capital initiated with an Outperform at Wolfe Research
08/16/21 Morgan Stanley
Arch Capital resumed with an Equal Weight at Morgan Stanley
07/09/21 BofA
Progressive added to US 1 List; Arch Capital removed at BofA
04/14/21 RBC Capital
Arch Capital price target raised to $47 from $41 at RBC Capital
VCYT Veracyte
$41.57 /

+0.01 (+0.02%)

06/28/21 Raymond James
Veracyte price target raised to $50 from $45 at Raymond James
06/15/21 Raymond James
Veracyte initiated with an Outperform at Raymond James
06/15/21 Raymond James
Veracyte initiated with an Outperform at Raymond James
06/03/21 Goldman Sachs
Veracyte initiated with Not Rated at Goldman Sachs
RLAY Relay Therapeutics
$29.29 /

+1.04 (+3.68%)

08/17/21 H.C. Wainwright
Relay Therapeutics price target lowered to $54 from $57 at H.C. Wainwright
07/21/21 BofA
BofA starts possible 'breakout star' Relay Therapeutics at Buy
07/21/21 BofA
Relay Therapeutics initiated with a Buy at BofA
03/29/21 JMP Securities
Relay Therapeutics price target lowered to $50 from $66 at JMP Securities
VCYT Veracyte
$41.57 /

+0.01 (+0.02%)

RLAY Relay Therapeutics
$29.29 /

+1.04 (+3.68%)

QTRX Quanterix
$41.23 /

-2.38 (-5.46%)

GERN Geron
$1.33 /

+0.005 (+0.38%)

ACGL Arch Capital
$40.18 /

-0.78 (-1.90%)

  • 13
    Oct
  • 04
    Feb
  • 05
    Feb
VCYT Veracyte
$41.57 /

+0.01 (+0.02%)

RLAY Relay Therapeutics
$29.29 /

+1.04 (+3.68%)

QTRX Quanterix
$41.23 /

-2.38 (-5.46%)

GERN Geron
$1.33 /

+0.005 (+0.38%)

WWR Westwater Resources
$3.49 /

+0.09 (+2.65%)

GERN Geron
$1.33 /

+0.005 (+0.38%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.